Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 25.4.2022 | EN | Official Journal of the European Union | C 171/31 |

---

Judgment of the General Court of 2 March 2022 — UGA Nutraceuticals v EUIPO — Vitae Health Innovation (VITADHA)

(Case T-149/21) [(1)](#ntr1-C_2022171EN.01003101-E0001)

(EU trade mark - Opposition proceedings - International registration designating the European Union - Word mark VITADHA - Earlier Spanish word mark VITANADH - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

(2022/C 171/40)

Language of the case: English

Parties

Applicant: UGA Nutraceuticals Srl (Gubbio, Italy) (represented by: M. Riva, J. Graffer and A. Ottolini, lawyers)

Defendant: European Union Intellectual Property Office (represented by: A. Folliard-Monguiral, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Vitae Health Innovation, SL (Montmeló, Spain) (represented by: E. Torner Lasalle, lawyer)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 15 January 2021 (Case R 2719/2019-4), relating to opposition proceedings between Vitae Health Innovation and UGA Nutraceuticals.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders UGA Nutraceuticals Srl to pay the costs. |

---

---

[Top](#document1)